73
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Assessment of treatment response in chronic constipation clinical trials

, , , , , , & show all
Pages 191-198 | Published online: 03 Jun 2014

References

  • HigginsPDJohansonJFEpidemiology of constipation in North America: a systematic reviewAm J Gastroenterol200499475075915089911
  • LemboACamilleriMChronic constipationN Engl J Med2003349141360136814523145
  • CamilleriMKerstensRRykxAVandeplasscheLA placebo-controlled trial of prucalopride for severe chronic constipationN Engl J Med2008358222344235418509121
  • WaldAScarpignatoCKammMAThe burden of constipation on quality of life: results of a multinational surveyAliment Pharmacol Ther200726222723617593068
  • DuboisDGiletHViala-DantenMTackJPsychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipationNeurogastroenterol Motil2010222e54e6319761492
  • SunSXDibonaventuraMPurayidathilFWWagnerJSDabbousOModyRImpact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness SurveyDig Dis Sci20115692688269521380761
  • CashBDChangETalleyNJWaldAFresh perspectives in chronic constipation and other functional bowel disordersRev Gastroenterol Disord20077311613317928791
  • AshrafWParkFLofJQuigleyEMAn examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipationAm J Gastroenterol199691126328561138
  • DrossmanDARome Foundation [webpage on the Internet]The Rome III process and classification [Presentation]Raleigh, NCRome Foundation, Inc2006 Available from: http://www.romecriteria.org/slides/criteria.cfmAccessed July 27, 2012
  • ThompsonWGLongstrethGFDrossmanDAHeatonKWIrvineEJMüller-LissnerSAFunctional bowel disorders and functional abdominal painGut199945Suppl 2II43II4710457044
  • DrossmanDARichterJETalleyNJCorazziariEThompsonWGWhiteheadWEFunctional Gastrointestinal DisordersBostonLittle, Brown1994
  • DrossmanDACorazziariETalleyNJThompsonWGWhiteheadWERome II: The Functional Gastrointestinal Disorders2nd edMcLean (VA)Degnon Associates2000
  • DrossmanDACorazziariEDelvauxMSpillerRCTalleyNJThompsonWGWhiteheadWERome III: The Functional Gastrointestinal Disorders3rd edMcLean (VA)Degnon Associates2006
  • Rome Foundation, Inc [webpage on the Internet]Rome III disorders and criteriaRaleigh, NCRome Foundation, Inc2006 Available from: http://www.romecriteria.org/criteria/Accessed July 27, 2012
  • Di PalmaJASmithJRClevelandMVOvernight efficacy of polyethylene glycol laxativeAm J Gastroenterol20029771776177912135034
  • ParkmanHPRaoSSReynoldsJCFunctional Constipation Study InvestigatorsNeurotrophin-3 improves functional constipationAm J Gastroenterol20039861338134712818279
  • JohansonJFWaldATougasGEffect of tegaserod in chronic constipation: a randomized, double-blind, controlled trialClin Gastroenterol Hepatol20042979680515354280
  • KammMAMüller-LissnerSTalleyNJTegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational studyAm J Gastroenterol2005100236237215667494
  • US Department of Health and Human ServicesFood and Drug AdministrationGuidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Draft GuidanceRockville, MDUS Department of Health and Human Services; Food and Drug Administration2006 Available from: http://www.fda.gov/ohrms/dockets/98fr/06d-0044-gdl0001.pdfAccessed July 27, 2012
  • US Department of Health and Human ServicesFood and Drug AdministrationGuidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling ClaimsRockville, MDUS Department of Health and Human Services; Food and Drug Administration2009 Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdfAccessed July 27, 2012
  • PatrickDLBurkeLBGwaltneyCJContent validity – establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1 – eliciting concepts for a new PRO instrumentValue Health201114896797722152165